Arbutus Biopharma Corporation (ABUS)

NASDAQ: ABUS · Real-Time Price · USD

3.215

-0.025 (-0.77%)

At close: Jul 25, 2025, 4:00 PM

3.220

+0.005 (0.16%)

After-hours: Jul 25, 2025, 4:11 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Novel Therapeutics	18.14M	Log In	Log In	Log In	Log In	Upgrade
Novel Therapeutics Growth	-53.51%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United States	18.14M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-53.51%	Log In	Log In	Log In	Log In	Upgrade